These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2581392)

  • 1. Rat alpha 1 macroglobulin inhibits hemagglutination by influenza C virus.
    Herrler G; Geyer R; Müller HP; Stirm S; Klenk HD
    Virus Res; 1985 Mar; 2(2):183-92. PubMed ID: 2581392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of influenza C virus inhibitor in rat serum.
    Kitame F; Nakamura K; Saito A; Sinohara H; Homma M
    Virus Res; 1985 Oct; 3(3):231-44. PubMed ID: 2416143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The nature of the influenza C virus receptor and the specificity of the receptor-destroying enzyme].
    Herrler G; Schauer J; Rott R; Klenk HD
    Vopr Virusol; 1987; 32(3):300-3. PubMed ID: 2445106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of influenza C virus inhibitors in rat serum.
    Kitame F; Nakamura K; Saito A; Sinohara H; Homma M
    Vaccine; 1985 Sep; 3(3 Suppl):211-4. PubMed ID: 4060850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection.
    Hanaoka K; Pritchett TJ; Takasaki S; Kochibe N; Sabesan S; Paulson JC; Kobata A
    J Biol Chem; 1989 Jun; 264(17):9842-9. PubMed ID: 2470764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin.
    Pritchett TJ; Paulson JC
    J Biol Chem; 1989 Jun; 264(17):9850-8. PubMed ID: 2470765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum.
    Ryan-Poirier KA; Kawaoka Y
    Virology; 1993 Apr; 193(2):974-6. PubMed ID: 7681613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of the erythrocyte receptors for influenza C virus.
    Ohuchi M; Homma M; Muramatsu M; Ohyama S
    Microbiol Immunol; 1978; 22(4):197-203. PubMed ID: 211399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase.
    Herrler G; Rott R; Klenk HD; Müller HP; Shukla AK; Schauer R
    EMBO J; 1985 Jun; 4(6):1503-6. PubMed ID: 2411539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum inhibitors of A 2 -Hong Kong influenza virus haemagglutination.
    Shortridge KF; Lansdell A
    Microbios; 1972 Dec; 6(24):213-9. PubMed ID: 4348986
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of alpha-macroglobulins and murinoglobulins on the hemagglutination by influenza C virus.
    Kitame F; Nakamura K; Saito A; Suzuki Y; Sinohara H; Homma M
    Biochem Int; 1986 May; 12(5):649-52. PubMed ID: 2425807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition.
    Mammen M; Dahmann G; Whitesides GM
    J Med Chem; 1995 Oct; 38(21):4179-90. PubMed ID: 7473545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of enzymes on the attachment of influenza and encephalomyocarditis viruses to erythrocytes.
    Burness AT; Pardoe IU
    J Gen Virol; 1981 Aug; 55(Pt 2):275-88. PubMed ID: 6270264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.
    Kendal AP
    Virology; 1975 May; 65(1):87-99. PubMed ID: 49979
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of -type inhibitor of influenza virus haemagglutination in human serum.
    Caliò R
    Boll Ist Sieroter Milan; 1972; 51(3):200-10. PubMed ID: 4120020
    [No Abstract]   [Full Text] [Related]  

  • 16. Substiuted sialic acid prosthetic groups as determinants of viral hemagglutination.
    Levinson B; Pepper D; Belyavin G
    J Virol; 1969 May; 3(5):477-83. PubMed ID: 4306720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoenzymatic synthesis and application of a sialoglycopolymer with a chitosan backbone as a potent inhibitor of human influenza virus hemagglutination.
    Makimura Y; Watanabe S; Suzuki T; Suzuki Y; Ishida H; Kiso M; Katayama T; Kumagai H; Yamamoto K
    Carbohydr Res; 2006 Aug; 341(11):1803-8. PubMed ID: 16716273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of the oligosaccharides of influenza viral glycoproteins.
    Nakamura N; Compans RW
    Virology; 1979 Feb; 93(1):31-47. PubMed ID: 433157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and antigenic characterization of the carbohydrate side chains of an Asian (N2) influenza virus neuraminidase.
    Ward CW; Murray JM; Roxburgh CM; Jackson DC
    Virology; 1983 Apr; 126(1):370-5. PubMed ID: 6189288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of asparagine-linked oligosaccharide structures of chronic lymphocytic leukemia cells.
    Volman GN; Narasimhan S; Letarte M
    Mol Immunol; 1987 Aug; 24(8):871-86. PubMed ID: 3498886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.